Tolerogenic dendritic cells ( DrugBank: - )
2 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 46 | 悪性関節リウマチ | 2 |
| 96 | クローン病 | 1 |
46. 悪性関節リウマチ
臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03337165 (ClinicalTrials.gov) | December 2016 | 3/11/2017 | Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis | Safety/Efficacy of Intra-articular Administration of Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis | Musculoskeletal Diseases;Joint Disease;Arthritis;Arthritis, Rheumatoid;Rheumatic Diseases;Connective Tissue Diseases;Autoimmune Diseases;Immune System Diseases | Biological: tolerogenic dendritic cells | Russian Academy of Medical Sciences | NULL | Completed | 18 Years | 75 Years | All | 10 | Phase 1 | Russian Federation |
| 2 | NCT01352858 (ClinicalTrials.gov) | February 2012 | 11/5/2011 | Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA) | Phase 1 Study of Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis | Rheumatoid Arthritis | Drug: TolDC;Drug: Arthroscopy & saline irrigation alone | Newcastle University | Arthritis Research UK;Newcastle-upon-Tyne Hospitals NHS Trust | Unknown status | 18 Years | N/A | All | 15 | Phase 1 | United Kingdom |
96. クローン病
臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02622763 (ClinicalTrials.gov) | November 2015 | 1/12/2015 | Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment | Safety and Clinical Efficacy Evaluation of Intralesional Administration of Tolerogenic Dendritic Cells in Patients With Refractory Crohn's Disease | Crohn's Disease | Biological: Tolerogenic Dendritic Cells | Fundacion Clinic per a la Recerca Biomédica | NULL | Terminated | 18 Years | 65 Years | All | 3 | Phase 1 | Spain |